What You Need For either format: Lyophilized peptide vial(s) separate retatrutide + cagrilintide, or one pre-mixed reta+cagri blend Bacteriostatic water (BAC water) sterile water with 0.9% benzyl alcohol preservative 30 mL syringe with 22-gauge needle for transferring BAC water 100-unit insulin syringes (U-100) for individual draws Alcohol swabs for vial-stopper sterilization Sharps container for used needles Clean flat surface with hands washed Pre-Mixed 12.5 / 2.5 mg Vial Reconstitution The 12.5/2.5 mg vial holds 15 mg total peptide (12.5 mg retatrutide + 2.5 mg cagrilintide) in a 5:1 mass ratio
13 people have viewed this Product
To view a copy of this licence, visit About this article Cite this article Zhang, T., Ruan, HZ., Wang, YC
The effectiveness of compounded semaglutide may vary and may not be equivalent to FDA-approved products
If tirzepatide is producing the desired outcomes, there is no compelling reason to switch to a less proven compound with more side effects
Mix protein powder into PB creating protein-enhanced spread
